11.29.11
Haupt Pharma’s site in Toride, Japan was successfully inspected at the end of October by Ibaraki prefecture, the local authority, without any significant observation being issued. The inspection covered all GMP areas and was conducted for the renewal of a manufacturing licence.
“Particularly against the background of the earthquake disaster in March of this year, the result of the inspection underlines the expertise and commitment of the site’s team, which contributed to this very good result,” said Keizo Yanagisawa, managing director of Haupt Pharma Toride.
The site manufactures sterile drugs in 1 ml, 2 ml and 5 ml ampoules, which are sterilized in their final container through processes such as microwave sterilization and steam autoclaves. Haupt Pharma Toride offers the service of subjecting imported bulk goods (injectables) to a visual inspection and then labelling and packaging them for the Japanese market. This service is also offered for products that require cold chain storage.
“Particularly against the background of the earthquake disaster in March of this year, the result of the inspection underlines the expertise and commitment of the site’s team, which contributed to this very good result,” said Keizo Yanagisawa, managing director of Haupt Pharma Toride.
The site manufactures sterile drugs in 1 ml, 2 ml and 5 ml ampoules, which are sterilized in their final container through processes such as microwave sterilization and steam autoclaves. Haupt Pharma Toride offers the service of subjecting imported bulk goods (injectables) to a visual inspection and then labelling and packaging them for the Japanese market. This service is also offered for products that require cold chain storage.